Adma Biologics (ADMA)

$9.15 -0.10 (-1.08%)
Market Cap 2.20B
Revenue (ttm) 510.17M
Net Income (ttm) 146.93M
EPS (ttm) N/A
PE Ratio 12.75
Forward PE 8.68
Profit Margin 28.80%
Debt to Equity Ratio 0.15
Volume 8,055,700
Avg Vol 5,215,766
Day's Range N/A - N/A
Shares Out 238.16M
Stochastic %K 22%
Beta 0.51
Analysts Strong Sell
Price Target $30.00

Company Profile

ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. The company operates through ADMA BioManufacturing and Plasma Collection Centers segments. The company offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the tre...

Industry: Biotechnology
Sector: Healthcare
Phone: 201-478-5552
Fax: 201-478-5553
Address:
465 State Route 17, Ramsey, United States
EquityGuidance
EquityGuidance Mar. 31 at 5:47 AM
$ADMA biotech name, just watching calmly.
0 · Reply
DragonAlgo
DragonAlgo Mar. 31 at 5:15 AM
🐉 $ADMA CALL — DragonAlgo® Signal Contract: ADMA CALL Expiry: 2026-04-17 | Strike: $10.00 | Type: CALL Option Plan (premium): Entry: $0.84 Stop: $0.60 TP1: $1.09 TP2: $1.43 TP3: $2.02 🔗 https://dragonalgo.com
0 · Reply
MomentumDailyChannel
MomentumDailyChannel Mar. 31 at 4:35 AM
$ADMA biotech name, just keeping an eye.
0 · Reply
Eagley3k
Eagley3k Mar. 31 at 2:10 AM
$ADMA Max Pain at $14
0 · Reply
Eagley3k
Eagley3k Mar. 31 at 2:09 AM
$ADMA "ADMA has filed its Annual Reports on Form 10-K for the years ended December 31, 2024 and 2025 with reports from a Big Four accounting firm that expressed unqualified opinions on the effectiveness of the Company’s internal control over financial reporting and an assessment that the Company’s consolidated financial statements are presented fairly, in all material respects, in conformity with U.S. generally accepted accounting principles (GAAP) for such periods."
0 · Reply
Eagley3k
Eagley3k Mar. 31 at 2:04 AM
$ADMA If FDA approves sBLA in April, it validates the pipeline and it would enhance margins thus confirming revenue guidance. This would work hand in hand with the strong company rebuttal that professionally addressed point by point the culper's short report and even filed it with SEC.
0 · Reply
Mr_Maniacal
Mr_Maniacal Mar. 31 at 1:39 AM
$ADMA @kiraoninjective Bot much?
1 · Reply
fredbull
fredbull Mar. 31 at 1:38 AM
$ADMA since trump bro taco ed out, we should see a short squeeze here this week https://www.wsj.com/world/middle-east/trump-iran-war-strait-of-hormuz-ee950ad4?gaa_at=eafs&gaa_n=AWEtsqeWylNSsTA1pZT4BtaSWdZfouVX9xEVhupqHdl7KO_ke30onjue8Z2SRQvobY4%3D&gaa_ts=69cb2902&gaa_sig=kXJfLwRwNN6bGfpj68f-mc_eIe4L3o_7X00_ypZXQg98_VuSPDxfPKAcLFDH_wBNOWj-bxmu_CTy0R8TOhryeQ%3D%3D
1 · Reply
kirk1985
kirk1985 Mar. 31 at 1:22 AM
$ADMA “ADMA recently announced a $125M accelerated buyback as part of a $200M plan—could support the stock. Also seeing improving analyst sentiment. Still watching price action for confirmation.”
0 · Reply
kirk1985
kirk1985 Mar. 31 at 1:18 AM
$ADMA https://www.stocktitan.net/news/ADMA/adma-biologics-announces-125-million-accelerated-share-repurchase-x9ps7wzvym17.html?utm_source=chatgpt.com
0 · Reply
Latest News on ADMA
ADMA Biologics, Inc. (ADMA) Crashes 16% Amid Scrutiny Over Skyrocketing Days Sales Outstanding That Short Seller Claims Points to Improper Channel Stuffing, Hagens Berman Investigating

Mar 30, 2026, 3:47 PM EDT - 11 hours ago

ADMA Biologics, Inc. (ADMA) Crashes 16% Amid Scrutiny Over Skyrocketing Days Sales Outstanding That Short Seller Claims Points to Improper Channel Stuffing, Hagens Berman Investigating

$ADMA Investor News: ADMA Biologics Faces Securities Fraud Investigation after Culper Research Revelation Leads to 29% Stock Drop – BFA Law Notifies Investors to Act

Mar 30, 2026, 6:07 AM EDT - 21 hours ago

$ADMA Investor News: ADMA Biologics Faces Securities Fraud Investigation after Culper Research Revelation Leads to 29% Stock Drop – BFA Law Notifies Investors to Act

ADMA Biologics Issues Statement Refuting Unsubstantiated, Misleading and Inaccurate Allegations by Culper Research

Mar 27, 2026, 7:00 AM EDT - 3 days ago

ADMA Biologics Issues Statement Refuting Unsubstantiated, Misleading and Inaccurate Allegations by Culper Research

$ADMA Shareholders: ADMA Biologics Hit with Securities Fraud Investigation After Stock Slides 29% Amid Channel Stuffing Claims – Investors with Losses Alerted to Contact BFA Law

Mar 27, 2026, 6:18 AM EDT - 3 days ago

$ADMA Shareholders: ADMA Biologics Hit with Securities Fraud Investigation After Stock Slides 29% Amid Channel Stuffing Claims – Investors with Losses Alerted to Contact BFA Law

ADMA BREAKING INVESTIGATION: BFA Law Launches Investigation into ADMA Biologics after Short Seller Report -- Investors Notified to Contact BFA Law

Mar 26, 2026, 2:34 PM EDT - 4 days ago

ADMA BREAKING INVESTIGATION: BFA Law Launches Investigation into ADMA Biologics after Short Seller Report -- Investors Notified to Contact BFA Law

Short Seller Report Alleges ADMA Biologics Financial Misrepresentation

Mar 25, 2026, 1:22 PM EDT - 5 days ago

Short Seller Report Alleges ADMA Biologics Financial Misrepresentation

ADMA Biologics Addresses Misleading Short-Seller Report

Mar 25, 2026, 6:30 AM EDT - 5 days ago

ADMA Biologics Addresses Misleading Short-Seller Report

ADMA Biologics Announces $125 Million Accelerated Share Repurchase with JPMorgan as Part of a Planned $200 Million 2026 Total Share Repurchase Initiative

Mar 2, 2026, 7:00 AM EST - 4 weeks ago

ADMA Biologics Announces $125 Million Accelerated Share Repurchase with JPMorgan as Part of a Planned $200 Million 2026 Total Share Repurchase Initiative

ADMA Biologics, Inc. (ADMA) Q4 2025 Earnings Call Transcript

Feb 25, 2026, 6:27 PM EST - 4 weeks ago

ADMA Biologics, Inc. (ADMA) Q4 2025 Earnings Call Transcript

ADMA Biologics Reports Record Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Feb 25, 2026, 4:05 PM EST - 4 weeks ago

ADMA Biologics Reports Record Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

ADMA Biologics to Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026

Feb 18, 2026, 7:00 AM EST - 5 weeks ago

ADMA Biologics to Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026

ADMA Biologics: Business Update And My Price Target

Jan 14, 2026, 9:17 AM EST - 2 months ago

ADMA Biologics: Business Update And My Price Target

ADMA Biologics, Inc. (ADMA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 12, 2026, 4:16 PM EST - 2 months ago

ADMA Biologics, Inc. (ADMA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

ADMA Biologics Announces Preliminary Full Year 2025 Unaudited Total Revenue and Provides Business Update

Jan 12, 2026, 8:00 AM EST - 2 months ago

ADMA Biologics Announces Preliminary Full Year 2025 Unaudited Total Revenue and Provides Business Update

ADMA Biologics to Present at the J.P. Morgan Healthcare Conference on January 12, 2026

Jan 5, 2026, 7:00 AM EST - 3 months ago

ADMA Biologics to Present at the J.P. Morgan Healthcare Conference on January 12, 2026

ADMA Biologics: Why The Dip To $16 Resets The Buy Case

Nov 20, 2025, 4:35 PM EST - 4 months ago

ADMA Biologics: Why The Dip To $16 Resets The Buy Case

ADMA Biologics, Inc. (ADMA) Q3 2025 Earnings Call Transcript

Nov 6, 2025, 3:31 AM EST - 5 months ago

ADMA Biologics, Inc. (ADMA) Q3 2025 Earnings Call Transcript

ADMA Biologics Announces Third Quarter 2025 Financial Results and Provides Business Update

Nov 5, 2025, 4:05 PM EST - 5 months ago

ADMA Biologics Announces Third Quarter 2025 Financial Results and Provides Business Update

ADMA Biologics to Report Third Quarter 2025 Financial Results on November 5, 2025

Oct 29, 2025, 7:00 AM EDT - 5 months ago

ADMA Biologics to Report Third Quarter 2025 Financial Results on November 5, 2025

3 Biotech Stocks I Am Accumulating

Oct 15, 2025, 2:30 PM EDT - 5 months ago

3 Biotech Stocks I Am Accumulating

HRMY INCY SNDX XBI

ADMA Biologics: Strong Product Mix, Growing Margins And Compelling Upside

Sep 3, 2025, 6:12 AM EDT - 7 months ago

ADMA Biologics: Strong Product Mix, Growing Margins And Compelling Upside

ADMA Biologics: Optionality With SG-001 And A Vertically Integrated IG Platform

Aug 10, 2025, 9:15 AM EDT - 8 months ago

ADMA Biologics: Optionality With SG-001 And A Vertically Integrated IG Platform

ADMA Biologics: A Better Quarter Than Headline Numbers

Aug 8, 2025, 3:58 PM EDT - 8 months ago

ADMA Biologics: A Better Quarter Than Headline Numbers

ADMA Biologics, Inc. (ADMA) Q2 2025 Earnings Call Transcript

Aug 6, 2025, 9:14 PM EDT - 8 months ago

ADMA Biologics, Inc. (ADMA) Q2 2025 Earnings Call Transcript

ADMA Biologics Announces Second Quarter 2025 Financial Results and Provides Business Update

Aug 6, 2025, 4:05 PM EDT - 8 months ago

ADMA Biologics Announces Second Quarter 2025 Financial Results and Provides Business Update

ADMA Biologics to Report Second Quarter 2025 Financial Results on August 6, 2025

Jul 30, 2025, 7:00 AM EDT - 8 months ago

ADMA Biologics to Report Second Quarter 2025 Financial Results on August 6, 2025

ADMA Biologics: Slowing Growth Warrants A Shift To Neutral (Rating Downgrade)

Jun 15, 2025, 4:11 AM EDT - 10 months ago

ADMA Biologics: Slowing Growth Warrants A Shift To Neutral (Rating Downgrade)

ADMA Biologics: Ready For More Growth Despite Q1 Earnings Miss

May 9, 2025, 3:54 AM EDT - 11 months ago

ADMA Biologics: Ready For More Growth Despite Q1 Earnings Miss

ADMA Biologics, Inc. (ADMA) Q1 2025 Earnings Call Transcript

May 7, 2025, 11:05 PM EDT - 11 months ago

ADMA Biologics, Inc. (ADMA) Q1 2025 Earnings Call Transcript

ADMA Biologics Announces First Quarter 2025 Financial Results and Provides Business Update

May 7, 2025, 4:05 PM EDT - 11 months ago

ADMA Biologics Announces First Quarter 2025 Financial Results and Provides Business Update

ADMA Biologics to Report First Quarter 2025 Financial Results on May 7, 2025

Apr 30, 2025, 7:00 AM EDT - 11 months ago

ADMA Biologics to Report First Quarter 2025 Financial Results on May 7, 2025

ADMA Biologics Announces U.S. FDA Approval of Innovative Production Yield Enhancement Process

Apr 28, 2025, 7:00 AM EDT - 1 year ago

ADMA Biologics Announces U.S. FDA Approval of Innovative Production Yield Enhancement Process

ADMA Biologics Statement on Tariffs

Apr 7, 2025, 7:00 AM EDT - 1 year ago

ADMA Biologics Statement on Tariffs

ADMA Biologics: Premium Valuation Justified By Strong Fundamentals And Future Potential

Mar 21, 2025, 3:04 PM EDT - 1 year ago

ADMA Biologics: Premium Valuation Justified By Strong Fundamentals And Future Potential

BREAKING: Block & Leviton Investigating ADMA Biologics, Inc. for Securities Fraud Violations Following Delayed 10-K and KPMG Evaluation of Controls

Mar 4, 2025, 1:50 PM EST - 1 year ago

BREAKING: Block & Leviton Investigating ADMA Biologics, Inc. for Securities Fraud Violations Following Delayed 10-K and KPMG Evaluation of Controls

ADMA Biologics, Inc. (ADMA) Q4 2024 Earnings Call Transcript

Mar 3, 2025, 6:24 PM EST - 1 year ago

ADMA Biologics, Inc. (ADMA) Q4 2024 Earnings Call Transcript

ADMA Biologics Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Mar 3, 2025, 4:05 PM EST - 1 year ago

ADMA Biologics Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

ADMA Biologics to Participate in the Raymond James Institutional Investor Conference

Feb 28, 2025, 7:00 AM EST - 1 year ago

ADMA Biologics to Participate in the Raymond James Institutional Investor Conference

ADMA Biologics to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025

Feb 25, 2025, 7:00 AM EST - 1 year ago

ADMA Biologics to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025

ADMA Biologics: Recent Pullback Is A Perfect Opportunity To Add

Feb 6, 2025, 1:46 PM EST - 1 year ago

ADMA Biologics: Recent Pullback Is A Perfect Opportunity To Add

ADMA Biologics Announces Partial Paydown of Senior Term Loan Credit Facility

Dec 20, 2024, 7:00 AM EST - 1 year ago

ADMA Biologics Announces Partial Paydown of Senior Term Loan Credit Facility

ADMA Biologics, Inc. Is Being Investigated For Securities Fraud And Investors With Losses Are Urged To Contact The Schall Law Firm

Dec 13, 2024, 5:15 PM EST - 1 year ago

ADMA Biologics, Inc. Is Being Investigated For Securities Fraud And Investors With Losses Are Urged To Contact The Schall Law Firm

EquityGuidance
EquityGuidance Mar. 31 at 5:47 AM
$ADMA biotech name, just watching calmly.
0 · Reply
DragonAlgo
DragonAlgo Mar. 31 at 5:15 AM
🐉 $ADMA CALL — DragonAlgo® Signal Contract: ADMA CALL Expiry: 2026-04-17 | Strike: $10.00 | Type: CALL Option Plan (premium): Entry: $0.84 Stop: $0.60 TP1: $1.09 TP2: $1.43 TP3: $2.02 🔗 https://dragonalgo.com
0 · Reply
MomentumDailyChannel
MomentumDailyChannel Mar. 31 at 4:35 AM
$ADMA biotech name, just keeping an eye.
0 · Reply
Eagley3k
Eagley3k Mar. 31 at 2:10 AM
$ADMA Max Pain at $14
0 · Reply
Eagley3k
Eagley3k Mar. 31 at 2:09 AM
$ADMA "ADMA has filed its Annual Reports on Form 10-K for the years ended December 31, 2024 and 2025 with reports from a Big Four accounting firm that expressed unqualified opinions on the effectiveness of the Company’s internal control over financial reporting and an assessment that the Company’s consolidated financial statements are presented fairly, in all material respects, in conformity with U.S. generally accepted accounting principles (GAAP) for such periods."
0 · Reply
Eagley3k
Eagley3k Mar. 31 at 2:04 AM
$ADMA If FDA approves sBLA in April, it validates the pipeline and it would enhance margins thus confirming revenue guidance. This would work hand in hand with the strong company rebuttal that professionally addressed point by point the culper's short report and even filed it with SEC.
0 · Reply
Mr_Maniacal
Mr_Maniacal Mar. 31 at 1:39 AM
$ADMA @kiraoninjective Bot much?
1 · Reply
fredbull
fredbull Mar. 31 at 1:38 AM
$ADMA since trump bro taco ed out, we should see a short squeeze here this week https://www.wsj.com/world/middle-east/trump-iran-war-strait-of-hormuz-ee950ad4?gaa_at=eafs&gaa_n=AWEtsqeWylNSsTA1pZT4BtaSWdZfouVX9xEVhupqHdl7KO_ke30onjue8Z2SRQvobY4%3D&gaa_ts=69cb2902&gaa_sig=kXJfLwRwNN6bGfpj68f-mc_eIe4L3o_7X00_ypZXQg98_VuSPDxfPKAcLFDH_wBNOWj-bxmu_CTy0R8TOhryeQ%3D%3D
1 · Reply
kirk1985
kirk1985 Mar. 31 at 1:22 AM
$ADMA “ADMA recently announced a $125M accelerated buyback as part of a $200M plan—could support the stock. Also seeing improving analyst sentiment. Still watching price action for confirmation.”
0 · Reply
kirk1985
kirk1985 Mar. 31 at 1:18 AM
$ADMA https://www.stocktitan.net/news/ADMA/adma-biologics-announces-125-million-accelerated-share-repurchase-x9ps7wzvym17.html?utm_source=chatgpt.com
0 · Reply
kirk1985
kirk1985 Mar. 31 at 1:16 AM
$ADMA Buyback New Release, link shared https://ir.admabiologics.com/news-releases/news-release-details/adma-biologics-announces-125-million-accelerated-share?utm_source=chatgpt.com
0 · Reply
Gfdtgcdryg
Gfdtgcdryg Mar. 31 at 1:09 AM
$ADMA Roth maxed for the year - government said I can’t buy more ADMA. You must do the rest of the work yourselves brothers
1 · Reply
kirk1985
kirk1985 Mar. 31 at 12:18 AM
$ADMA This may have already been shared, but Im sharing this just in case; subject to form your own opinion accordingly. https://ir.admabiologics.com/news-releases/news-release-details/adma-biologics-issues-statement-refuting-unsubstantiated#:~:text=Release%20Details-,ADMA%20Biologics%20Issues%20Statement%20Refuting%20Unsubstantiated%2C%20Misleading,Inaccurate%20Allegations%20by%20Culper%20Research&text=RAMSEY%2C%20N.J.%20and%20BOCA%20RATON,the%20past%20two%2Dplus%20years.
0 · Reply
Gfdtgcdryg
Gfdtgcdryg Mar. 31 at 12:16 AM
$ADMA if they are going to keep it cheap, I guess I’ll keep buying
1 · Reply
StockBraker
StockBraker Mar. 30 at 10:38 PM
$ADMA Just a reminder-patience is a virtue.
0 · Reply
fredbull
fredbull Mar. 30 at 9:24 PM
$ADMA large scale sell orders have dried up quite a bit. So, I think we move up rest of the week imo
1 · Reply
kirk1985
kirk1985 Mar. 30 at 8:55 PM
$ADMA ? Dow seems to be holding up better today while tech is struggling. Could be rotation into safer stocks with everything going on (oil, inflation). Still feels like an uncertain market—just what I’m seeing.
1 · Reply
Erod70
Erod70 Mar. 30 at 7:30 PM
$ADMA up to 55.5k shares. 5.5k more than my old position. 🤫😂😎
2 · Reply
StockBraker
StockBraker Mar. 30 at 7:25 PM
$ADMA Maybe we should try this method. https://x.com/SolSammi/status/2038609691916284105?s=20
2 · Reply
kirk1985
kirk1985 Mar. 30 at 7:05 PM
$ADMA Dow Jones observation...
0 · Reply
Erod70
Erod70 Mar. 30 at 6:47 PM
$ADMA we got this💪😎
1 · Reply
BeefStewart
BeefStewart Mar. 30 at 6:24 PM
$ADMA I have never been physically intimate with a man before; but that shouldn't preclude me from commenting on what I believe is a significantly undervalued stock. We are now talking about a profitable company that has demonstrated sizable, durable growth! My only wish is that I had more dry powder.
1 · Reply